SCHEMBL6256382

SCHEMBL6256382

CC1=C(C(c2ccccc2)(c2ccccc2)c2ccccc2)CC=C1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.34
MAPK1 P28482 1/20 0.31
TSHR P16473 2/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12814833 0.82 ESR1 (0.39) KCNN4MAPK1ALDH1A1
SCHEMBL12815372 0.82 ACHE (0.37) MAPK1ALDH1A1
SCHEMBL6269864 0.81
SCHEMBL9349636 0.80
SCHEMBL16458819 0.79 MAPK1 (0.32) MAPK1ALDH1A1
SCHEMBL9353359 0.78 KIF11 (0.30)
SCHEMBL12815663 0.77 MAPK1 (0.33) KCNN4MAPK1ALDH1A1
SCHEMBL12815653 0.76
SCHEMBL12815123 0.76 KCNN4 (0.33) KCNN4
SCHEMBL12815309 0.76 APOBEC3A (0.32) KCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1380601-B1 Supported Ziegler - metallocene catalyst composition and process for olefin polymerization and olefin copolymerization with alpha olefins using novel catalyst systems SAUDI BASIC IND CORP (SA) 2005-05-25 EP claimed
EP-2691357-A1 METHOD FOR PRODUCING 1-HEXENE Sumitomo Chemical Company Limited (JP) 2014-02-05 EP disclosed
US-20140012056-A1 METHOD FOR PRODUCING 1-HEXENE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-09 US disclosed
WO-2012133937-A1 METHOD FOR PRODUCING 1-HEXENE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140012056-A1 METHOD FOR PRODUCING 1-HEXENE AP2A1, AP1M1, ME1 KCNN4 3730/4885MAPK1 400/4885TSHR 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.